The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MINNEAPOLIS, Minnesota –- Device company Vascular Solutions Inc. has received clearance from the U.S. Food and Drug Administration to market its GuideLiner catheter — a device the company thinks ...

WASHINGTON, DC—An analysis looking at adverse events related to use of two different guide extension catheters reported to the US Food and Drug Administration should spur operators to use these ...

Both devices also receive reimbursement designation from the Japanese Ministry of Health, Labour and Welfare Japan Lifeline Co., Ltd., which supervised the regulatory and reimbursement submissions, ...

Please provide your email address to receive an email when new articles are posted on . Teleflex Inc. announced that the FDA has granted an expanded indication for its specialty catheters and coronary ...

WASHINGTON (Reuters) – A U.S. appeals court on Tuesday lifted a preliminary injunction on Boston Scientific Corp’s catheter product Guidezilla that had been issued by a lower court as part of a patent ...

The utility of a guideliner™ catheter in retrograde percutaneous coronary intervention of a chronic total occlusion with reverse cart-the "capture" technique. Intimal hyperplasia and vascular ...

After extended legal proceedings, a federal appeals court reaffirmed an injunction issued in December against sales of Boston Scientific's ($BSX) Guidezilla catheter ...

Vascular Solutions, Inc., recently announced that it has sued Boston Scientific Corporation for allegedly infringing on three of its patents related to guided catheter products. Maple Grove-based ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will ...